Loading…
ATTIA is a brand name for Dipyridamole. The medicine, its uses, side effects and dosage are the same regardless of brand.
Used for: • Secondary prevention of ischaemic stroke and transient ischaemic attacks either alone or in conjunction with aspirin. • An adjunct to oral anti-coagulation for prophylaxis of thromboembolism associated with prosthetic heart valves.
Verbatim from this product's MHRA label. Tap a section to expand.
For oral administration Adults, including the elderly The recommended dose is one capsule twice daily, usually one in the morning and one in the evening preferably with meals. The capsules should be swallowed whole without chewing. Children Attia/Dipyridamole Dr.
Reddy’s Modified-Release Capsules is not recommended for children. Alcohol Attia/Dipyridamole Dr. 5).
Adverse reactions at therapeutic doses are usually mild and transient. As a result of its vasodilating properties, Attia/Dipyridamole Dr. Reddy’s Modified-Release Capsules may cause hypotension, hot flushes and tachycardia. Worsening of the symptoms of coronary heart disease such as angina and arrhythmias.
The following side effects have been reported, frequencies have been assigned based on clinical trial (ESPS-2) in which 1654 patients received dipyridamole alone. 4 Special warnings and precautions for use). Reporting of suspected adverse reactions Reporting suspected adverse reactions after authorisation of the medicinal products is important.
It allows continued monitoring of the benefit/risk balance of the medicinal product. uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store.
Among other properties, dipyridamole acts as a potent vasodilator. g. decompensated heart failure). Patients being treated with regular oral doses of Attia/Dipyridamole Dr. Reddy’s Modified-Release Capsules should not receive additional intravenous dipyridamole.
Clinical experience suggests that patients being treated with oral dipyridamole who also require pharmacological stress testing with intravenous dipyridamole, should discontinue drugs containing oral dipyridamole for twenty-four hours prior to stress testing.
In patients with myasthenia gravis readjustment of therapy may be necessary after changes in dipyridamole dosage (See Interactions). Attia/Dipyridamole Dr. Reddy’s Modified-Release Capsules should be used with caution in patients with coagulation disorders.
A small number of cases have been reported in which unconjugated dipyridamole was shown to be incorporated into gallstones to a variable extent (upto 70% by dry weight of stone). These patients were all elderly, had evidence of ascending cholangitis and had been treated with oral dipyridamole for a number of years.
There is no evidence that dipyridamole was the initiating factor in causing gallstones to form in these patients. It is possible that bacterial deglucuronidation of conjugated dipyridamole in the bile may be the mechanism responsible for the presence of dipyridamole in gallstones.
Attia/Dipyridamole Dr. Reddy’s Modified-Release Capsules capsules contain ponceau 4R (E124), a colouring agent, which may cause allergic reactions.
Hypersensitivity to any component of the product
Not medical advice. Always read the patient information leaflet and follow your prescriber or pharmacist.
Other brands of Dipyridamole in United Kingdom.
Know a brand we are missing in United Kingdom? Suggest a brand →
Brand names are compiled from public regulatory records for active-ingredient mapping only. Drugvu is not affiliated with any manufacturer. This is not medical advice.